HLA-C and colorectal cancer: In addition to the variability in morphological, phenotypic, functional, or genetic characteristics, the heterogeneity in colorectal cancer can be also found in aspects related to the expression of molecules involved in antitumor immune-surveillance, specially the major histocompatibility complex (MHC).